Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INSMED Inc Director's Dealing 2023

Oct 31, 2023

30150_dirs_2023-10-31_ea35671e-f305-4128-954b-352bc9e14612.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2023-10-27

Reporting Person: Lewis William (Director, Chair and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-10-27 Common Stock M 53363 $14.24 Acquired 53363 Indirect
2023-10-27 Common Stock S 53363 $24.04 Disposed 0 Indirect
2023-10-27 Common Stock M 1322 $14.24 Acquired 1322 Indirect
2023-10-27 Common Stock S 1322 $25.08 Disposed 0 Indirect
2023-10-27 Common Stock M 315 $14.24 Acquired 315 Indirect
2023-10-27 Common Stock S 315 $26 Disposed 0 Indirect
2023-10-27 Common Stock M 500 $14.24 Acquired 500 Indirect
2023-10-27 Common Stock M 55350 $14.24 Acquired 289274 Indirect
2023-10-27 Common Stock S 55350 $24.04 Disposed 233924 Indirect
2023-10-27 Common Stock M 1323 $14.24 Acquired 235247 Indirect
2023-10-27 Common Stock S 1323 $25.05 Disposed 233924 Indirect
2023-10-27 Common Stock M 327 $14.24 Acquired 234251 Indirect
2023-10-27 Common Stock S 327 $26 Disposed 233924 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-10-27 Stock Option (right to buy) $14.24 M 55000 Disposed 2023-10-31 Common Stock (55000) Indirect
2023-10-27 Stock Option (right to buy) $14.24 M 500 Disposed 2023-10-31 Common Stock (500) Indirect
2023-10-27 Stock Option (right to buy) $14.24 M 57000 Disposed 2023-10-31 Common Stock (57000) Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 342648 Direct

Footnotes

F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2: By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A11/1/2020

F3: This is the weighted average sales price representing 53,363 shares sold at prices ranging from $23.68 to $24.60 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

F4: This is the weighted average sales price representing 1,322 shares sold at prices ranging from $24.83 to $25.40 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

F5: By ARTICLE 4 KATIE PROCTER DYNASTY TRUST

F6: This is the weighted average sales price representing 55,350 shares sold at prices ranging from $23.65 to $24.63 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

F7: This is the weighted average sales price representing 1,323 shares sold at prices ranging from $24.83 to $25.40 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

F8: Includes 1,303 shares acquired through the Company's 2018 Employee Stock Purchase Plan.

F9: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable and were scheduled to expire on October 31, 2023.